PAR 3.88% 49.5¢ paradigm biopharmaceuticals limited..

Clinical Trials - why the expense?

  1. 19 Posts.
    lightbulb Created with Sketch. 2
    I've been wondering, why is it so expensive for a clinical trial? Don't they just advertise at hospitals and clinics for people, pay them x amount for a few visitations and then simply submit the data to the relevant authorities for review?
    Take a look at the below chart for a breakdown of a couple of aliments. It's expensive, no wonder PAR would find it advantageous to partner with a larger Phrama Company to assist with this. As far as I can understand we are in a good position, our PAR has some $10 M in cash so if needs be we can go it alone, but certainly an advantage to find an appropriate partner for this, and future steps, to bring about commercialisation.
    ----------------------------------------------------------------------------------------------------------------------------------------------------------


    https://hotcopper.com.au/data/attachments/1472/1472087-7a7aaaed6ff0397592f4572867263331.jpg
    Source: https://www.centerpointclinicalservices.com/blog-posts/driving-drive-drug-innovation-and-market-access-part-1-clinical-trial-cost-breakdown/
    Do your own research of course.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
49.5¢
Change
-0.020(3.88%)
Mkt cap ! $82.30M
Open High Low Value Volume
51.0¢ 52.5¢ 49.0¢ $492.8K 981.6K

Buyers (Bids)

No. Vol. Price($)
4 18016 49.0¢
 

Sellers (Offers)

Price($) Vol. No.
50.0¢ 43020 2
View Market Depth
Last trade - 16.10pm 03/12/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.